Cargando…
Large Scale Conversion of Trilobolide into the Payload of Mipsagargin: 8-O-(12-Aminododecanoyl)-8-O-Debutanoylthapsigargin
In spite of the impressing cytotoxicity of thapsigargin (Tg), this compound cannot be used as a chemotherapeutic drug because of general toxicity, causing unacceptable side effects. Instead, a prodrug targeted towards tumors, mipsagargin, was brought into clinical trials. What substantially reduces...
Autores principales: | Zimmermann, Tomáš, Drašar, Pavel, Rimpelová, Silvie, Christensen, Søren Brøgger, Khripach, Vladimir A., Jurášek, Michal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762042/ https://www.ncbi.nlm.nih.gov/pubmed/33291419 http://dx.doi.org/10.3390/biom10121640 |
Ejemplares similares
-
BODIPY-based fluorescent liposomes with sesquiterpene lactone trilobolide
por: Škorpilová, Ludmila, et al.
Publicado: (2017) -
Mipsagargin: The Beginning—Not the End—of Thapsigargin Prodrug-Based Cancer Therapeutics
por: Isaacs, John T., et al.
Publicado: (2021) -
Thapsigargin—From Thapsia L. to Mipsagargin
por: Andersen, Trine Bundgaard, et al.
Publicado: (2015) -
Mitotic Poisons in Research and Medicine
por: Škubník, Jan, et al.
Publicado: (2020) -
Flavonoids and Related Members of the Aromatic Polyketide Group in Human Health and Disease: Do They Really Work?
por: Tauchen, Jan, et al.
Publicado: (2020)